Distalmotion closes $90M Series E financing to support its Dexter surgical robot

[Image from Distalmotion]Surgical robot maker Distalmotion announced today that it closed a Series E financing round worth proceeds of $90 million.

Revival Healthcare Capital led the round, with participation from 415 Capital and existing investors.

According to a news release, Lausanne, Switzerland-based Distalmotion intends to use the funding to support the global commercialization of its Dexter surgical robot. Dexter received CE mark approval in Europe in December 2020.

Distalmotion designed Dexter for laparoscopic surgery in the fields of genera, gynecological and urological surgery. The company said the latest investment arrives as the platform takes its first steps into the operating room and the imminent commercial rollout looms.

The company says that the Dexter system combines the affordability of laparoscopy with the benefits of robotic surgery to increase simplicity and versatility in the space. Leading European hospitals are currently spea…

Read more
  • 0